Applied DNA Sciences Inc (APDN)

[mcsharkey]

Happy Memorial Day 2020 Foose, and all, a year we're not likely to forget. Pulling for us all, came across some recent notes of interest for you guys (me too). Figured I'll give you the meat, let me correct that. Chips and salsa, dig around in it if you like. Maintain your social distancing.

Covid news is your BIG DEAL. Just last quarter it was invasive Circulating Tumor Cells with TYME Technologies. On that:

Seeking Alpha ---Tyme Technologies, Inc. (TYME) - May 20, 2020 Earnings Call Transcript
from Dr. Giuseppe Del Priore, Chief Medical Officer:

This slide demonstrates important circulating tumor cell results in Part 1 of TYME-88 Panc, patients who had at least an 80% reduction in the circulating tumor cells trended towards a greater survive, with a 60% reduction in the risk of death.......Overall, about half of patients achieved at least an 80% reduction in their circulating tumor cell burden.
This is important since Tyme is playing a significant role in advancing the development of circulating tumor cells......

See November 2019 business announcement of 3000 kits made available to TYME from Vitatec. Clinical trials carry both O&M and R&D costs Operations & Maintenance; Research & Development..my take

Looking good for Vitatex kits. Thanks to Park, we have a picture of what the primary container in LineaRX's test kit looks like (Picture Credit to Vitatec page, Park didn't take it):

How it works is another story.

IMHO, You guys are looking great in iCTC diagnostic testing for the huge Cancer irradication field.

Nuther opinion follows on your latest funding offer, lot of cash needed for Clinical Trials, here's a link to a Clinical Trial that failed, BTW, just shows you the Gov's clinical trial data base you may want to get used to.

Foose, that 2018 trial record is from TYME's prime competitor (IMHO, again). AND, they're a Stoney Brook University entity. Probably a lab or two down from Doc Hayward's office. I'm agreeing with you, my mentioning of Renaissance Tech in my last post wasn't intended as a distraction.

Renaissance heavily aligned to supporting Stoneybrook U bio-tech though and they're venture capital buy-in and bundling into holdings company got failing Rafael Pharma to a listing on New York Stock Exchange earlier this year. Many believe Rafael's current Clinical Trial portfolio driven cash from Renaissance, who is now letting it's fledgling fly:

https://fintel.io/i/renaissance-technologies-llc
Renaissance Technologies LLC reports 6.18% decrease in ownership of RFL / Rafael Holdings, Inc.
May 14, 2020 - Renaissance Technologies LLC has filed a 13F-HR form disclosing ownership of 437,550 shares of Rafael Holdings, Inc. (NYSE:RFL) with total holdings valued at $5,605,000 USD as of March 31, 2020. Renaissance Technologies LLC had filed a previous 13F-HR on February 13, 2020 disclosing 466,350 shares of Rafael Holdings, Inc. at a value of $8,320,000 USD. This represents a change in shares of -6.18 percent and a change in value of -32.63 percent during the quarter...

So, RENAISSANCE has both extensive Venture Capitalist projects.

AND they support Stoney Brook University aligned bio-medical...Nuts, killing this topic. Apologies all around.

RENAISSANCE buy-in would be a great sign you guys are on to something.

Be Safe, Be Well, and GLTUA